Angiogenesis is regulated by angiopoietins during experimental autoimmune encephalomyelitis and is indirectly related to vascular permeability

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 12, 2011, Pages 1107-1123

  MacMillan, Carolyn J ^a   Starkey, Ryan J ^a   Easton, Alexander S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Angiogenesis; Angiopoietin 1; Angiopoietin 2; Bloodbrain barrier; Experimental autoimmune encephalomyelitis; Vascular endothelial growth factor; Vascular permeability

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CD3 ANTIGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPINAL CORD;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEUROGLIA; NEURONS; RECEPTOR, TIE-2; SPINAL CORD;

EID: 81855199918     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31823a8b6a     Document Type: Article

References (60)

1. Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: Cause or consequence? Angiogenesis 2007;10:149Y66
2. Szekanecz Z, Besenyei T, Paragh G, et al. Angiogenesis in rheumatoid arthritis. Autoimmunity 2009;42:563Y73
3. Szekanecz Z, Koch AE. Mechanisms of disease: Angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol 2007;3:635Y43
4. Bar-Or A. Immunology of multiple sclerosis. Neurol Clin 2005;23:149Y75
5. Peterson JW, Trapp BD. Neuropathobiology of multiple sclerosis. Neurol Clin 2005;23:107Y29
6. Ludwin SK, Henry JM, McFarland HF. Vascular proliferation and angiogenesis in MS: Clinical and pathogenic implications. J Neuropathol Exp Neurol 2001;60:505
7. Holley JE, Newcombe J, Whatmore JL, et al. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci Lett 2010;470:65Y70
8. Kirk SL, Karlik SJ. VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 2003;21:353Y63
9. Roscoe WA, Welsh ME, Carter DE, et al. VEGF and angiogenesis in acute and chronic MOG(35Y55) peptide induced EAE. J Neuroimmunol 2009;209:6Y15
10. Seabrook TJ, Littlewood-Evans A, Brinkmann V, et al. Angiogenesis is present in experimental allergic encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J Neuroinflamm 2010; 7:95
11. Proescholdt MA, Jacobson S, Tresser N, et al. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 2002;61:914Y25
12. Tham E, Gielen AW, Khademi M, et al. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand J Immunol 2006;64:609Y22
13. Daniel PM, Lam DK, Pratt OE. Relation between the increase in the diffusional permeability of the bloodYcentral nervous system barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat. J Neurol Sci 1983;60:367Y76
14. Juhler M, Barry DI, Offner H, et al. Blood-brain and bloodYspinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res 1984;302:347Y55
15. Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the bloodbrain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990; 113:1477Y89
16. Hawkins CP, Mackenzie F, Tofts P, et al. Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain 1991;114:801Y10
17. Floris S, Blezer EL, Schreibelt G, et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: A quantitative MRI study. Brain 2004;127:616Y27
18. Spitsin S, Portocarrero C, Phares TW, et al. Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein. J Neuroimmunol 2008;196:8Y15
19. Bennett J, Basivireddy J, Kollar A, et al. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol 2010;229:180Y91
20. Rumjanek VM, Leyton J, Morley J. Mononuclear cell accumulation and plasma protein extravasation (PPE) during induction, remission and re-challenge of experimental allergic encephalomyelitis in the rat. J Neurol Sci 1984;65:81Y92
21. Fabis MJ, Scott GS, Kean RB, et al. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc Natl Acad Sci U S A 2007;104:5656Y61
22. Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protoc 2006;1:1810Y19
23. Gauden V, Hu DE, Kurokawa T, et al. Novel technique for estimating cerebrovascular permeability demonstrates capsazepine protection following ischemia-reperfusion. Microcirculation 2007;14:767Y78
24. Joice SL, Mydeen F, Couraud P-O, et al. Modulation of blood-brain barrier permeability by neutrophils: In vitro and in vivo studies. Brain Res 2009;1298:13Y23
25. Rapoport SI. A mathematical model for vasogenic brain edema. J Theor Biol 1978;74:439Y67
26. Go KG. The normal and pathological physiology of brain water. Adv Tech Stand Neurosurg 1997;23:47Y142
27. Schlageter KE, Molnar P, Lapin GD, et al. Microvessel organization and structure in experimental brain tumors: Microvessel populations with distinctive structural and functional properties. Microvasc Res 1999;58: 312Y28
28. Easton AS, Sarker MH, Fraser PA. Two components of blood-brain barrier disruption in the rat. J Physiol 1997;503:613Y23
29. Alvarez JA, BairdA, TatumA, et al. Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms. Mod Pathol 1992;5:303Y7
30. Papavassiliou E, Gogate N, Proescholdt M, et al. Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J Neurosci Res 1997;49:451Y60
31. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 2000;12:4243Y54
32. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces TH1 polarization. J Immunol 2004;172:4618Y23
33. Plate KH. Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 1999;58:313Y20
34. Marti HJH, Bernaudin M, Bellail A, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000;156:965Y76
35. Stratmann A, Risau W, Plate KH. Cell typeYspecific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998;153:1459Y66
36. Beck H, Acker T, Wiessner C, et al. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol 2000;157:1473Y83
37. Nourhaghighi N, Teichert-Kuliszewska K, Davis J, et al. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest 2003;83:1211Y22
38. Ohab JJ, Fleming S, Blesch A, et al. A neurovascular niche for neurogenesis after stroke. J Neurosci 2006;26:13007Y16
39. Valable S, Bellail A, Lesne S, et al. Angiopoietin-1Yinduced PI3-kinase activation prevents neuronal apoptosis. Faseb J 2003;17:443Y45
40. Ward NL, Putoczki T, Mearow K, et al. Vascular-specific growth factor angiopoietin 1 is involved in the organization of neuronal processes. J Comp Neurol 2005;482:244Y56
41. Poncet S, Gasc JM, Janzer RC, et al. Expression of Tie-2 in human peripheral and autonomic nervous system. Neuropathol Appl Neurobiol 2003;29:361Y69
42. Kosacka J, Figiel M, Engele J, et al. Angiopoietin-1 promotes neurite outgrowth from dorsal root ganglion cells positive for Tie-2 receptor. Cell Tissue Res 2005;320:11Y19
43. De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8:211Y26
44. Hansen TM, Moss AJ, Brindle NP. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res 2008;5:236Y45
45. Kobayashi H, Lin PC. Angiopoietin/Tie2 signaling, tumor angiogenesis and inflammatory diseases. Front Biosci 2005;10:666Y74
46. Huang H, Bhat A, Woodnutt G, et al. Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 2010;10:575Y85
47. Lisak RP, Nedelkoska L, Studzinski D, et al. Cytokines regulate neuronal gene expression: Differential effects of TH1, TH2 and monocyte/macrophage cytokines. J Neuroimmunol 2011;238:19Y33
48. Huang YF, Yang CH, Huang CC, et al. Pharmacological and genetic accumulation of hypoxia-inducible factor-1alpha enhances excitatory synaptic transmission in hippocampal neurons through the production of vascular endothelial growth factor. J Neuroscience 2010;30:6080Y93
49. Easton AS. Regulation of permeability across the blood-brain barrier. In: Cheng CY, ed. Biology and Regulation of Blood-Tissue Barriers. Landes Bioscience and Springer Science and Business Media; 2011 [published online ahead of print]
50. Folcik VA, Smith T, O'Bryant S, et al. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: An additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors. J Neuroimmunol 1999;97: 119Y28
51. Bolton C, Paul C. MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J Pharmacol Exp Ther 1997;282: 397Y402
52. Kean RB, Spitsin SV, Mikheeva T, et al. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of bloodYcentral nervous system barrier integrity. J Immunol 2000;165: 6511Y18
53. Schreibelt G, Musters RJ, Reijerkerk A, et al. Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol 2006;177:2630Y37
54. Lu C, Diehl SA, Noubade R, et al. Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2010;107: 18967Y72
55. Gobel K, Pankratz S, Schneider-Hohendorf T, et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J Autoimmun 2011;36:106Y14
56. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008;14:25Y36
57. Sarker MH, Easton AS, Fraser PA. Regulation of cerebral microvascular permeability by histamine in the anaesthetized rat. J Physiol 1998;507: 909Y18
58. Inglis VI, Jones MP, Tse AD, et al. Neutrophils both reduce and increase permeability in a cell culture model of the blood-brain barrier. Brain Res 2004;998:218Y29
59. Hu DE, Easton AS, Fraser PA. TRPV1 activation results in disruption of the blood-brain barrier in the rat. Br J Pharmacol 2005;146:576Y84
60. Cowan KM, Easton AS. Neutrophils block permeability increases induced by oxygen glucose deprivation in a culture model of the human blood-brain barrier. Brain Res 2010;1332:20Y31